forget the chart , page-4

Raider,
We have been through this chart debate before.

Your reasons for paying not much attention to it are sound based on past bio tech experiences especially in Aus.

However I think looking at charts for Bios such as CXS provide a fresh perspective an an interesting outlook. Please keep up the charting analysis nirdac.

Not sure if you ever compare CXS and CXSP in your charting analysis. Do the charts look similar?

I have been very impressed by the strength in the share price of late, especially with all of the blood on the floor of late. Could some of the strength be related to perceptions that BIO's such as CXS are reasonably stable cash wise and perhaps a safe haven for cash when times in other sectors are tough?

Beers